[1] [1] D. A. Carson, M. R. Joao. Apoptosis and disease. Lancet, 1993, 341:1251～1254

[3] [3] Z. Darzynkiewicz, J. Gloria, L. Xun et al.. Cytometry in cell necrobiology: analysis of apoptosis and accidental cell death (necrosis). Cytometry, 1997,27(1):1～20

[4] [4] C. H. E. Homburg, H. de Masja, E. G. B. Albert et al.. Human neutrophils lose their surface FcyRIII and acquire Annexin V binding sites during apoptosis in vitro. Blood, 1995, 85(2):532～540

[5] [5] M. Castedo, H. Tamara, A. S. Santos et al.. Sequential asquistion of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J. Immunol., 1996, 157(4):512～521

[6] [6] G. Koopman, C. P. M. Reutelingsperger, R. M. J. Kuijten et al.. Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood, 1994, 84(5):1415～1420

[7] [7] S. Shimizu, Y. Eguchi, W. Kamiike et al.. Bcl-2 blocks loss of mitochondrial transmembrane potential while ICE inhibitors act at a different step during inhibition of death induced by respiratory chain inhibitors. Oncogene, 1996, 13(1):21～30

[8] [8] J. F. R. Kerr, A. H. Wyllie, A. R. Curie. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer, 1972, 26(2):239～257

[9] [9] G. Majno, I. Joris. Apoptosis, oncosis, and necrosis, an overview of cell death. Am. J. Pathol, 1995, 146(1):3～16

[10] [10] C. R. Knight, R. C. Rees, M. Griffin. Apoptosis: a potential role for cytosolic transglutaminase and its importance in turmour progression. Biochim. Biophys. Acta, 1991, 1096(2):312～318

[11] [11] V. A. Fadok, D. R. Voclker, P. A. Cammpbell et al.. Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immumol., 1992, 148(8):2207～2216